9 3 39 (Lamotrigine 25 mg)
Pill with imprint 9 3 39 is White, Four-sided and has been identified as Lamotrigine 25 mg. It is supplied by Teva Pharmaceuticals USA.
Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; seizure prevention; epilepsy and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 9 3 39
Lamotrigine
- Imprint
- 9 3 39
- Strength
- 25 mg
- Color
- White
- Size
- 8.00 mm
- Shape
- Four-sided
- Availability
- Prescription only
- Drug Class
- Triazine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- National Drug Code (NDC)
- 00093-0039 (Discontinued)
- Inactive Ingredients
-
silicon dioxide,
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
povidone k30,
corn starch,
sodium starch glycolate type A potato
Note: Inactive ingredients may vary.
Related images for "9 3 39"
More about lamotrigine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (1,540)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: triazine anticonvulsants
Patient resources
- Drug Information
- Lamotrigine (Advanced Reading)
- Lamotrigine Chewable Dispersible Tablets
- Lamotrigine Extended-Release Tablets
- Lamotrigine Orally Disintegrating Tablets
- Lamotrigine Tablets
- Other brands
- Lamictal, Lamictal XR, Subvenite, Lamictal ODT, Lamictal CD
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.